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P u r p o s e .  T o  identify pathogenic  m utations in th e  guanylate 
cyclase-activating p ro te in  1 (GCAPl') and GCAP2 genes and to 
characterize th e  biochem ical effect o f m utation on guanylate 
cyclase (GC) stim ulation.
M e t h o d s .  The G CAPl and GCAP2 genes w ere  screened  by 
direct sequencing for m utations in 216 patien ts and 421 pa­
tients, respectively, w ith various hereditary retinal diseases. A 
m utation in GCAPl segregating w ith  autosom al dom inant cone 
degeneration w as fu rther evaluated biochem ically by em ploy­
ing recom binant p roteins, im m unoblotting, Ca2+-dependent 
stim ulation of GC, fluorescence emission spectra, and limited 
proteolysis in th e  absence and  p resence  of Ca2+.
R e s u l t s .  A novel GCAPl m utation, I143NT (substitution of He 
at codon  143 by Asn and  Thr), affecting th e  EF4 Ca2+-binding 
loop, w as identified in a heterozygote father and son w ith 
autosom al dom inant cone degeneration. Both patien ts had 
m uch g reater loss o f cone function versus rod  function; previ­
ous histopathologic evaluation o f th e  father's eyes at autopsy 
(age 75 years) show ed no foveal cones bu t a few, scattered  
cones rem aining in th e  peripheral retina. Biochem ical analysis 
show ed  tha t th e  GCAP 1-1143NT m utant adop ted  a conform a­
tion  susceptib le to  proteolysis, and  th e  m utant inhibited GC 
only partially at high Ca2+ concentrations. Individual patients 
w ith  atypical o r recessive retinitis p igm entosa (RP) had addi­
tional heterozygous G C A P l-\'\X i\ and GCAP2 gene changes 
(V85M and F150C) of unknow n pathogenicity.
C o n c l u s io n s .  A novel GCAPl m utation, 1143NT, caused a form 
of autosom al dom inant cone degeneration tha t destroys foveal 
cones by mid-life bu t spares som e cones in th e  peripheral
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retina u p  to  75 years. P roperties o f th e  GCAP1-I143NT m utant 
p ro te in  suggested tha t it is incom pletely inactivated by high 
Ca2+ concentrations as should occu r w ith  dark adaptation. The 
con tinued  activity o f th e  m utant GCAPl likely results in higher- 
than-norm al scotopic cGMP levels w hich may, in turn , account 
for th e  progressive loss o f cones. (In vest O ph tha lm ol Vis Sci. 
2004;45:3863-3870) D 0l:10 .1 l67/iovs.04-0590
U  od  and cone photo transduction  cascades rapidly activate a 
X V cG M P phosphodiesterase w hen  rhodopsin  is pho toacti­
vated. The final steps of th e  photo transduction  cascade are a 
reduction  of cytoplasm ic cGMP and th e  closure o f cGMP-gated 
cation channels in th e  plasm a m em brane . 1 To recover from a 
pho to response, cGMP m ust be replenished by p h o to recep to r 
guanylate cyclases (GCs). W hen th e  level o f cGMP (1 -10  /u,M) 
is replenished, cGMP-gated channels reopen, and dark-adapted 
Ca2+ levels (6 00 -1000  nM) are restored. Activity o f th e  pho­
to recep to r GC is regulated via retina-specific guanylate cyclase- 
activating proteins, o r GCAPs. In th e  dark, w hen  th e  intracel­
lular Ca2+ level is relatively high due to  its continuous influx 
th rough  open  channels, Ca2+-bound GCAPs are inactive. In the 
light, th e  closed channels result in reduced  Ca2+ levels, 
thereby  allowing th e  Ca2+ ions to  dissociate from th e  GCAPs. 
Ca2+-free GCAPs are th en  able to  stim ulate GC, resulting in an 
acceleration of cGMP synthesis. D isruption of these  events by 
m utations in genes encoding PDE subunits ,2-1 G O ,5-6 
G CA Pl,7~9 and  th e  subunits o f th e  rod  and  cone cGMP-gated 
channels , 1" " 15 cause p h o to recep to r degenerations such as re t­
initis pigm entosa, Leber congenital amaurosis, cone dystrophy, 
o r congenital stationary night blindness. 16-17
M ultiple GCAP gene duplications have taken p lace during 
evolution. Up to  eight GCAPs (GCAPl to  -8) have been identi­
fied in te leosts . 18 In th e  mammalian retina, only th ree  GCAP 
isoform s (GCAPl to  -3) are expressed . 19 In hum ans, GCAPl 
and GCAP2 are encoded  by a tail-to-tail gene array on chrom o­
som e 6p 2" w hile th e  G CAPj gene is located on chrom osom e 
3 q .21 All th ree  GCAPs are expressed  in rods and cones , 19 but 
m utations in only th e  G CAPl gene have been  associated w ith 
hum an retinal disease, namely, autosom al dom inant cone dys­
trophy  (adCD). Cone-specific degenerations due to  G CAPl 
defects are consistent w ith  th e  high levels o f GCAPl in the  
o u te r segm ents o f th is cell type. O ne repo rted  m utation 
(Y99C) results in a Tyr to  Cys change in EF3.22-2-5 A nother 
m utation, E155G 9 replacing th e  last acidic residue of th e  EF 
hand w ith  a neutral residue, is p red ic ted  to  affect Ca2+ coor­
dination at EF4. Acidic Glu/Asp residues, occupying th e  first 
and last positions o f th e  loop, are required  for effective Ca2+ 
coord ination .21 E l55 is 100% conserved in all GCAPs se­
quenced  so far, suggesting tha t th is residue is essential. A th ird  
reportedly pathogenic  m utation (GCAP1-P50L) found in one 
family w ith  cone-rod dystrophy25 causes disease by an entirely 
different m echanism 26 o r may be a nonpathogenic  rare variant. 
No disease-causing m utations have yet been  repo rted  in the  
hum an GCAP227 and GCAPj genes.
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Table 1. PCR Primers Used in this Study
Prim er Exon Prim er Sequence
GCAPl
4949 IS 5 - GGACTCAGGCCTGTGAGAGA
4950 1A 5 - CCAGCTGGTCAGGCTTCC
4951 2-4S 5 - CGGAGCCTTGGGTTATGAT
4952 2-4 A 5 - GCGAGCTAAGCCTCTGAGTT
5094 2R* 5 - CCTCAGTCCCACATCCTGTC
5095 3F* 5 - TCTACTCCTCACTGCTCTTG
5097 4F* 5 - ACGTGGGCTCTGTCCCTGCC
GCAP2
5098 IS 5 - AGTCACCCAGGAGATGATGG
5099 1A 5 - ACGGAGTGGAAAGAAGAGCA
5100 2S 5 - GGCCACATGGATTAAAAGGA
5101 2A 5 - CACAGGAAACACACTCAGAATGA
5102 3S 5 - GTGATCCTAAGACGCACAGC
5103 3A 5 - TTCTCCACAGCCTTCTCACA
5104 4S 5 - TGAGGTCTGAGACTGCAGGA
5105 4A 5 - GAAGTCAACACCAGGGGAAGA
Exons terminating in an “S' are in the sense direction; those with 
“A' are in the antisense direction.
* These primers w ere used for sequencing the PCR product am­
plified by 4951 and 4952.
This con tribu tion  describes ou r recen t searches for m uta­
tions in th e  GCAPl and GCAP2 genes am ong patien ts w ith 
hereditary retinal diseases. Analysis o f th e  G CAPl gene w as 
focused on patien ts w hose disease included cone dysfunction 
o r degeneration  as a p rom inen t feature. Analysis o f th e  GCAP2 
gene included patients w ith  rod and cone dysfunction or de­
generation, since this gene is though t to  be expressed  in bo th  
ph o to recep to r cell types .2**"29
M a t e r ia l s  a n d  M e t h o d s
Ascertainm ent o f  Patients and Controls
This study conformed to the tenets of the Declaration of Helsinki and 
was approved by Internal Review Boards at the Massachusetts Eye and 
Ear Infirmary and Harvard Medical School. Almost all patients were 
recruited from the Berman-Gund Laboratory and were diagnosed with 
a hereditary retinal disease after an eye examination that included an 
electroretinogram (ERG). Patients with cone-rod degeneration had a 
substantially more severe reduction in cone versus rod ERG ampli­
tudes. Patients with retinitis pigmentosa had more severe reduction in 
rod versus cone ERG amplitudes o r had comparable reductions in rod 
and cone amplitudes. Patients with achromatopsia had absent color 
vision and severely reduced cone ERGs and normal to slightly subnor­
mal rod ERGs from early childhood. Patients with cone degeneration 
had reduced central visual acuity, a reduction in cone ERGs. and 
normal or slightly subnormal rod ERGs. Patients w ith cone dysfunction 
had some but not all clinical features diagnostic of cone degeneration 
or achromatopsia. Control individuals had no symptoms of hereditary 
retinal disease and had no known blood relatives with such diseases.
ERGs were recorded after maximal dilation of the pupil and at least 
40 minutes of dark-adaptation.3l,~32 Blood samples w ere obtained from 
the patients. Relatives of some patients w ere also recruited for this 
study and donated blood samples. Control blood samples w ere also 
obtained from individuals w ithout symptoms of or family history of 
retinal disease. Leukocyte DNA was purified using standard proce­
dures.
Mutation Screening
The open reading frames of the GCAPl and GCAP2  genes, including 
their flanking intron splice sites, w ere amplified using the polymerase 
chain reaction and the primers listed in Table 1. The DNA sequences 
w ere obtained by direct DNA sequencing using a dye-terminator cycle
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Table 2. Numbers and Diagnoses of Patients Screened
Diagnosis GCAPl GCAP2
Cone-rod degeneration 82 0
Atypical RP 50 56
Cone dysfunction 37 36
Achromatopsia 35 35
Cone degeneration 12 11
Dominant RP 0 190
Recessive RP 0 93
Total 216 421
sequencing kit (version 3.1; Applied Biosystems. Foster City. CA) and 
an automated sequencer (ABT model 3100; Applied Biosystems). The 
numbering of the codons of the cDNA of GCAPl and GCAP2 in this 
article are according to GenBank accession numbers L36859 and NM- 
002098. respectively21’-33; NT-007592 was used for the numbering of 
the genomic sequence for both genes (GCAPl and GCAP2 genes are 
separated by 5420 bp).
E xpression Constructs o f  Mutant GCAPs
The mutations w ere introduced into a human GCAPl plasmid (hG­
CAPl) by site-directed mutagenesis.'^ and the m utant GCAPs were 
expressed in insect cells. Briefly, the i'coRT-digested insert of hGCAPl 
was cloned into pFastBac-1. and transformed into XLI-Gold Esche­
richia coli strain. The orientation of the resulting plasmid was con­
firmed with Psll digests and the mutations w ere verified by DNA 
sequencing with the primers 5'-GTTGGCTACGTATACTCCGG and 5'- 
GTAAAACCTCTACAAATGTGG. Mutagenesis to generate GCAPl- 
T143NT was carried out in this plasmid using the sense primer 5'- 
CAGTGTTCTCCAAGAATACCGACGTCAACGGGGAT and the anti­
sense primer 5 '-ATCCCCGTTGACGTCGGTATTCTTGGAGAACACTG. 
Mutagenesis to generate GCAP1-E155G9 as an internal control was 
carried out with the sense primer 5'-AACTCTCCCTGGAAGGGTT- 
TATAGAGGGCGT and the anti-sense primer 5'-ACGCCCTCTATAAAC- 
CCTTCCAGGGAGAGTT. Wild-type human GCAPl. GCAP1-E155G. and 
GCAP1-T143NT pFastBac plasmids w ere transformed into DHIOBac E. 
coli to generate the recom binant bacmid DNAs (Bac-to-Bac Baculoviras 
Expression System. Tnvitrogen. Carlsbad. CA). The bacmids w ere trans­
fected into High five insect cells (Invitrogen) to produce recombinant 
baculoviras and proteins.
SDS PAGE and W estern Blot Analysis
The expression of GCAPl proteins was confirmed with UW101 antibody 
using SDS PAGE and Western blot analysis as described? ‘ All purification 
procedures were performed at 4°C. After homogenization. cell suspen­
sions were centrifuged at lOO.OOOg for 20 minutes. Again, all purification 
procedures were carried out at 4°C. Supernatants were used as a source 
of recombinant proteins for protein purification. GCAPs were purified 
using monoclonal antibody (G2) coupled to CNBr-activated Sepharose 
resin ( —5 mg TgG/1 ml, gel) as described previously.1”  Purified proteins 
were dialyzed overnight against 10 mM Bis-Tris Propane (1.3-bis(tris|hy-
T a b l e  3 .  Sequence Variants Identified in GCAPl Gene
Protein Nucleotide Patient Diagnosis
None c.-26A>G 065-001 Achromatopsia
TI 14T C .3 4 1 0 T 199-005 Atypical RP
T143NT c.428delTinsACAC 195-001 Cone degeneration
None g.IVS34 171delG 065-011* Achromatopsia
D189D C .5 7 7 0 T 111-007 Achromatopsia
D189D C .5 7 7 0 T 270-003 Macular degeneration
* This patient was later shown to be a homozygote with the 
pathogenic mutation T383ts in the CNGBJ gene encoding |3-subunit of 
the cone cGMP-gated channel (data not shown).
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F i g u r e  1. Analyses of family #3762 with GCAP1-I143NT and family 6551 with GCAP1-T1141. (A) Sequences of two novel missense changes in 
GCAPl and schematic pedigrees of the corresponding families. Filled symbols-, affected individuals; open symbols-, unaffected individuals. Arrows 
point to the sequence results of relevant family members. Boxes denote residues at the mutation site. (B) Dark-adapted, full-lield FRGs from a 
normal control individual (top), two patients with GCAP1-I143NT (middle), and a patient with GCAP1-T114I (bottom ). The patients with 
GCAPl-II43NT are individuals IV-1 and V-l of family #3762; the patient with GCAPl-T1141 is individual TTI-3 of family #6551. Going from left to 
right, the columns show rod responses to 0.5-Hz blue flashes (1.2 log ft/I.. Anlax =  440 nm). rod-plus-cone responses to 0.5-Hz w hite flashes (3.8 
log ft/I.), and cone responses to 30-Hz white flashes (3.8 log ft/I.). For all three columns, the scale bar (right colum n above the bottom  traces) 
indicates 100 fxV vertically and 50 ms horizontally. For each test condition, two to four consecutive sweeps are shown to illustrate reproducibility.
droxymethyl]amino) propane (pH 7.5). containing 100 mM NaCl at 4°C. 
The purity of the proteins was estimated by SDS-PAGF and Coomassie 
staining. SDS-PAGF in the presence and absence of Ca2 1. and limited 
proteolysis of purified GCAPl and GCAPl mutants, were carried out as 
described previously.1’0
GC Activity Assay
Washed rod outer segment (ROS) membranes1’7 w ere prepared from 
fresh bovine retinas reconstituted with recom binant GCAPs and as­
sayed as described.1’8 |Ca2+] was calculated using the com puter pro­
gram Chelator 1.OO1’9 and adjusted to higher concentrations by increas­
ing the amount of CaCU. AH assays w ere repeated at least twice.
Fluorescence M easurements
Fluorescence measurements of GCAPl and its mutants w ere carried 
out on a spectrofluorimeter (T.S 50B; Perkin-Flmer. Boston. MA) using 
a 1 X 1-cm quartz cuvette. Emission spectra w ere recorded with 
excitation at 280 nm at 5 nm slit widths. Spectra w ere determ ined in 
50 mM HEPES (pH 7.8). containing 60 mM KC1. 20 mM NaCl. 1 mM 
EGTA. 1 mM dithiothreitol. and 4.6X10 8 to 2.4X10 0 M CaCU.
R esu lts  a n d  D isc u ssio n  
GCAPl Gene Mutations
The GCAPl gene w as analyzed in 216 patien ts w ith  cone 
degeneration, co n e -ro d  degeneration, achrom atopsia, o r o ther 
hereditary retinal disease in w h ich  cones degenerate  o r are 
dysfunctional (Table 2). Five DNA sequence changes w ere
found in a total o f six patien ts (Table 3). O ne o f th e  changes, 
1143NT (c.428delTinsACAC), affected a residue in th e  a-helix 
im mediately flanking th e  Ca2+-binding site (KF4). This change




V85M c.253G>A 038-114 Atypical RP
N106N c.318T>C 001-473 Dominant RP
None g.TVS3H 22deIA 115-018 Cone dysfunction
None g.TVS3H 22deIA 001-051 Dominant RP
None g.TVS3H 65G>A 001-245 Dominant RP
F150C c.449T>G 003-059 Recessive RP
Polym orphism s
Allele Frequency*
Protein Nucleotide (h o m /h e t/h o m )
Y57Y c.l 71T>C 56/206/159
None g.TVS2H 81 C>T 299/83/8
E155Dt c.465G>T 410/11/0
None g.TVS2-74 G>A 9/96/280
None g.TVS3H 8G>A 402/15/0
N onet g.TVS3-30A>G 389/11/0
* Some patients w ere not included in the analysis of some poly­
morphisms.
t  Reported in Reference 27.
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F igure  2. Amino acid sequence of vertebrate GCAPls around EF4 and biochemical analysis o f m utant GCAPs. ( A) Sequence of vertebrate GCAPls 
around the Ca2 1 -binding loop EF4. EF4 is highlighted by gray shading, surrounded by two a-helical structures (approximately three helical turns). 
The mutations changing the hydrophobic residue lie 143 and the acidic residue E155 are identified by arrows. A third m utation found in an 
independent family (Fig. IB) is situated in the C-terminal helix of EF3. It is unclear w hether this m utation causes retinal disease. (B) Stimulation 
of GC activity in ROS membranes by normal and mutant GCAPs as a function of Ca2 1. The dark-shaded  area indicates low |Ca2 1 |m,. expected in 
the light-adapted photoreceptors: the light-shaded area reflects high |Ca2 1 |m.,. expected in the dark-adapted photoreceptors. Assays were carried 
out with addition of 3 M GCAPs and were repeated at least three times. Error bars: SD for GC activity stimulated by GCAPs. (C) Stained SDS gel 
of GCAPl. GCAP1-1143NT. and GCAP1-E155G in the presence or absence of Ca2 1 (colum n I): —. absence o f EGTA. + . presence of EGTA. Column  
2  is a control immunoblot for GCAPs in water. GCAPs display a shift in mobility in the absence of bound Ca2 1. The antibody used is UW14.2'
w as found in an index patien t w ith  autosom al dom inant cone 
degeneration, and it w as not found am ong 93 contro l individ­
uals. The index patien t IV-1 (family #3761) and his affected son 
V-l w ere  bo th  heterozygous for this change; th e  one unaf­
fected relative (a daughter, V-2) w ho  w as analyzed did not 
e a rn 7 th e  change (Fig. 1).
A missense change, T1141 (c.341C >T ), w as identified in 
ano ther index patien t, also a heterozygote, w ith  an atypical 
form of retinal degeneration (Fig. 1A). The patien t had no 
know n affected relatives, and th e  few  living unaffected rela­
tives could no t be located. Thus w e  could not determ ine 
w h e th e r they  also carried th is change. At age 29 years, the 
patien t had rod F.RG am plitudes reduced  approxim ately 70%- 
75% below  th e  low er limit o f norm al, and cone F.RG am plitudes 
reduced  only approxim ately 65% below  th e  low er limit of 
norm al (Fig. IB). This reduction  in rod  and cone FRC. ampli­
tudes w as very different from that found in previously reported  
patien ts w ith  G CAPl m utations and w as different from our 
patien t w ith  th e  C.CAP1-I143NT m utation.
Three o ther novel GCAPl changes w ere  found in one or 
tw o  patien ts each, all heterozygotes, and w ere  in terp re ted  as 
likely nonpathogenic rare variants: an A-to-C. transition in the 
5 '-untranslated region, a 1-bp deletion in intron 3, and an
isocoding change in codon 1)189 (Table 3). N one of these 
th ree  changes is p red ic ted  to  affect th e  am ino acid sequence of 
th e  encoded  protein . N one of these  th ree  changes, and neither 
th e  1143NT nor th e  T 1 141 change, appears to  create o r destroy 
any splice donor o r accep to r site, based on analysis w ith  
splice-site p red iction  softw are (available at h ttp ://w w w . 
fru itfly .org/seq_tools/splice.h tm l)."’
Ocular Findings o f  Patients w ith  GCAP1-I143NT
T he ocular findings and FRC.s of th e  affected father and son 
from th is family w ith  th e  C.CAF1-1143NT m utation have been 
previously reported . ' 1 A lthough th e  son at age 15 years had 
visual acuity o f 20/20 in bo th  eyes, his cone function w as 
severely com prom ised, as indicated by his absent color vision 
(i.e., his inability to  arrange th e  Farnsw orth D-15 panel o r to 
correctly  identify7 Hardy-Rand-Rittler (1IRR) color plates). The 
father at age 45 had photophob ia , visual acuity of 20/300 in 
bo th  eyes, absent color vision, and small regions of retinal 
atrophy in th e  cen te r of th e  macula of bo th  eyes. FRC.s o f both  
th e  father at age 45 and th e  son at age 25 show ed  minimal if 
any 30-1 Iz cone FRC. responses and intact 0.5-Hz rod FRC. 
responses to  b lue or w h ite  light (Fig. IB) . ' 1 Farly recep to r
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potential am plitudes after a bleaching light recovered  at a rate 
slow er than  norm al and  co rresponded  to  th e  normal rate of 
rhodopsin  regeneration, indicating little to  no cone func­
tio n / 2'13 The eyes of th e  father, obtained at autopsy at age 75, 
revealed th e  absence of rod  and cone pho to recep to rs  in the 
central macula; som e degenerating p h o to recep to r inner and 
ou ter segm ents w ere seen in th e  parafoveal region.-”  In the 
periphery , th e  rod pho to recep to rs  w ere intact and normal in 
num ber, and a few intact cone pho to recep to rs  w ere also
4 4presen t.
GCAP2 Gene Mutations
The G C APl gene was analyzed in 190 patien ts w ith autosomal 
dom inant retinitis pigm entosa, 93 w ith autosom al recessive 
retinitis pigm entosa, and 138 patien ts w ith various forms of 
retinal degeneration/dysfunction  (Table 2). Five rare variants 
w ere identified in a total of six heterozygous patien ts (Table 4). 
T w o of them  w ere missense changes, bo th  affecting residues in 
a-helices flanking th e  Ca2 ^-binding dom ain. A V85M m utation 
was found in a heterozygote pa tien t w ith atypical retinal de­
generation w ith  no family history. An F150C change was found 
in a heterozygous patien t w ith  recessive RP w ho w as the 
offspring of a consanguineous marriage. No likely m utation 
affecting th e  o th e r allele was identified in e ither patien t. The 
rem aining th ree  rare variants w ere  isocoding or intron changes 
p red ic ted  not to  affect th e  encoded  p ro te in  (Table 4). Six DNA 
sequence changes w ere found tha t w ere in terp re ted  as non- 
pathogenic  polym orphism s because they  w ere found in > 1% 
of alleles (Table 4). O ne of th e  polym orphism s is a previously 
rep o rted 27 m issense alteration (K155D) tha t affects th e  last 
residue in th e  highly conserved Ca2 ^-binding dom ain KF3. 
H owever, this m utation was previously also found in a normal 
con tro l.27 Splice-site p red iction  softw are found no evidence 
tha t any of th e  GCAP2 changes created  o r destroyed RNA 
splice sites.
Biochem ical Analysis o f  the  
GCAP1-I143NT Mutant
A lthough th e  C.CAP1-1143NT m utation cosegregated w ith  cone 
degeneration in family #3761, th e  available family m em bers 
w ere few in num ber and th e  cosegregation of th e  m utation 
w ith th e  disease could  have been  by chance. Further evidence 
for th e  pathogenicity  o f this m utation, how ever, cam e from 
analyses o f th e  ability o f th e  m utant recom binant p ro te in  to 
stim ulate GC as a function of [Ca2 ^].
The residue H el43 precedes th e  KF4 loop in GCAPl (Fig. 
2A). This position, typically occupied  by a hydrophobic resi­
due, is invariant in th e  KF4 hand  motifs o f GCAPl (Fig. 2A), and 
in th e  closely related GCAP2 and  GCAP3 sequences (not 
show n). To test th e  p resum ed  im portance of this residue for 
Ca2  ^ b inding, hum an GCAPl, th e  m utant GCAP1-1143NT, and 
th e  m utant GCAP1-K155G w hich had earlier been  show n to  be 
associated w ith  cone dystrophy ,9 w ere  expressed  in insect 
cells. W hen th e  affinity-purified pro te ins w ere analyzed by SDS 
PACK (Fig. 2C) in th e  p resence  of high Ca2  ^ (1 mM) and in the 
absence of Ca2  ^ (1 mM KGTA), norm al and  m utant GCAPls 
exhibited  a change in mobility ( “Ca2 '“-shift"). This mobility 
shift is typical for calmodulin-like Ca2 ^-binding p ro teins and 
indicated a large rearrangem ent of th e  3D structure from an 
open form (Ca2 ''-free, th e  slow er m oving active form ) to  a 
m ore com pact Ca2 ^-bound conform ation (the faster moving 
inactive form). The Ca2 '“-shift was som ew hat sm aller in the 
m utant proteins, consistent w ith  im paired Ca2 f' binding to 
HF4.
F ig u r e  3. C.a2""-induced conformational changes in GCAPl and its 
mutants observed by fluorescence spectroscopy. Changes in fluores­
cence at Ac,x -  290 nm and -  343 nm as a function of [Ca2 "]. 
Insets, fluorescence emission spectra of GCAPs using excitation at 280 
nm from 4.6 X 10 s M to 2.4 X 10 0 M Ca2 ". (A) Recombinant human 
GCAPl; (B) GCAP1-E155G; (C) GCAPl-T143NT.
Persistent Stimulation o f  Photoreceptor GC 
by GCAP1-I143NT
We nex t assayed th e  degree to  w hich m utant GCAP1-114.3NT 
stim ulated GC as a function of [Ca21-]. We ex p ec ted  incom ­
p le te  inactivation of G O  at th e  high Ca2  ^ levels found in 
dark-adapted pho to recep to rs, similar to  w hat has been  re­
p o rted  for GCAPl-Y99C22"23 and GCAP1-H155G.9 As show n in 
Figure 215, GCAP1-1143NT was active at low Ca2 H (< 2 0 0  nM), 
as was wild-type GCAPl, bu t th e  m utant rem ained active (30%- 
50%) even at high dark [Ca2 F]lrrt.-levels ( —700 nM) w hen 
wild-type GCAPl was inhibited. Similar incom plete suppres­
sion of GC activity was previously found w ith a GCAP1-Y99C 
m utation affecting HF3.23 The m utant GCAP1-H155G exhibited  
similar incom plete suppression of GC activity, suggesting that 
in bo th  m utants, as evidenced by th e  rightw ard shift in the 
Ca2 ^-titration curve, KF4 binds Ca2  ^ w ith  an im paired affinity. 
This conclusion is consistent w ith ou r previous finding tha t the 
GCAP1-K155D3'’ m utant, w hich is no t able to  b ind  Ca2  ^ to  this 
loop, show ed activity even at high, nonphysiological Ca2  ^
levels (50 /nM [Ca2 l‘]l-rvr). M utagenesis experim ents show ed 
tha t w hen  bo th  KF3 and  KF4 of GCAPl are defective and allow 
no Ca2  ^ binding, GCAPl was converted  into a Ca2 ^-insensitive 
GC stim ulator (Fig. 6B in Ref.36). Taken together, th e  findings
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indicate tha t Ca2+ binding by HF3 and HF4 is critical for inac­
tivation of GCAPl, and dissociation o f Ca2+ from these sites 
converts GCAPl from the  inactive to  an active state. Mutations 
affecting only one o f these sites will partially im pair GC inhi­
bition, leading to  persisten t stim ulation in dark-adapted p h o to ­
receptors.
Fluorescence Em ission Spectra o f  GCAPl Mutants
A sensitive assay for changes in Ca2+-binding is to  m easure 
intrinsic Trp fluorescence. Trp21 in th e  N-terminal domain, 
Trp51 betw een  FF1 and FF4, and T rp94 near FF3 can be used 
to  m onitor changes in conform ation w hen  excited  w ith  UV 
ligh t' 5 (Fig. 3). An increase of Ca2+ bound  to  GCAPl caused a 
decrease in fluorescence intensity w ith  a m inim um  occurring 
at 200-300  nM lCa2+ J(ree (Fig. 3A). Further increases in Ca2+ 
levels reversed this trend  and caused an increase in fluores­
cence intensity (Fig. 3A). These changes in th e  fluorescence 
correlated  w ith  a structural rearrangem ent o f GCAPl and a 
transition from an activator to  an inhibitor o f p h o to recep to r 
GC. However, w hen  the  GCAPl m utants w ere  analyzed, w e 
no ticed  a significantly modified dependence  of fluorescence 
intensity on Ca2+ levels: high Ca2+ levels did not increase the  
fluorescence of th e  m utant p ro teins (Figs. 3B and 3C) apart 
from a small shoulder at 3 0 0 -6 0 0  nM [Ca2+ J,ree. Since Trp 
residues w ere  no t p resen t only in th e  Ca2+-binding sites, the  
fluorescence data prov ided  general inform ation about struc­
tural changes in GCAPl, unrelated  to  specific regions such as 
FF4.
GCAPl Structure and the C onsequence o f  
I143NT Mutation
The four FF hands of GCAPl are arranged in pairs tha t gave rise 
to  N- and C-terminal dom ains w h ich  form a relatively com pact 
structure (Fig. 4). Three Ca2+ ions are bound  to  GCAPl at FF2, 
FF3, and FF4, as p red ic ted  on th e  basis o f its amino acid 
sequence and by num erous site-directed m utagenesis experi­
m ents. J7 FF1 does no t b ind Ca2+ because th e  bind­
ing loop is d istorted  by a Pro at th e  fourth position of th e  12 
residue loop. In addition, the  preced ing  residue (Cys) is not 
suitable for th e  coordination of Ca2+ ions. Modeling of FF4 of
F igure  4 . Model of GCAPl and dis­
tortion of EF4 by insertion of two 
residues. (A) The model of GCAPl is 
based on the NMR structure of 
GCAP2 (as deposited in the Protein 
Data Bank, PDTS TD# 1JBA).50 The N- 
terminal domain is in blue, the C- 
terminal domain is in red, and the 
central helix is in yellow . Ca2 1 ions 
are shown in blue, and the side 
chains of the residues Hel43 and 
Thrl 14 are shown with the van der 
Waals spheres. (B) A cartoon of EF4 
depicting how  the replacem ent of 
hydrophobic lie 143 by two polar res­
idues may lower affinity for Ca2 1. (C) 
lim ited  proteolysis of GCAPl and 
GCAPl-II43NT by trypsin. The diges­
tion was carried out at 30°C at a ratio 
of GCAPl/trypsin 300:1, and the di­
gest was analyzed by SDS-PAGE at 0,
5, 10, and 15 minutes; 4 Ca2 1 repre­
sents 2 fjM [C.a2+] and - C a 21 indi­
cates 30 nM [Ca21]. Note that al­
ready after 5 minutes of digestion, 
the high molecular weight compo­
nents are more extensively digested 
in GCAP1-T143NT.
GCAPl, based on th e  recoverin crystal s tru c tu re ,JS and the  
structure of GCAP2, revealed th rough  nuclear m agnetic reso­
nance techn iques , '9 suggests tha t substitution of lle l4 3 , posi­
tioned  at th e  N-terminal end  o f FF4, by tw o  polar residues will 
change th e  orientation o f th e  N-terminal a-helix, distorting the  
loop conform ation tha t is essential for Ca2+ binding, and de­
creasing the  affinity for Ca2+ (Figs. 4A and 4B). Changes in 
these positions am ong o ther Ca2+-binding pro te ins have also 
been  show n to  im pair Ca2+ coordination .2' The effect o f the  
m utation on the  structure  o f GCAPl can be m onitored  by 
subjecting GCAPl and GCAP1-1143NT to  lim ited proteolysis 
(Fig. 4C). In the  absence of Ca2+, GCAPl assum ed an open 
conform ation and w as readily digested by trypsin (last lane, 
bo th  gels). In th e  p resence  of Ca2+, GCAPl assum ed a com ­
p act structure, and proteolysis w as restricted. U nder th e  same 
conditions, GCAP1-1143NT, in w h ich  Ca2+-binding is im peded 
at FF4, w as m ore susceptible to  proteolysis.
T hrl 14 (Table 3), a residue w hich  w as m utated  to  lie in 
family 6551 (Fig. 1A), w as located on th e  C-terminal helix of 
FF3 (Fig. 4). Substitution at this conserved region am ong 
GCAPsls19 may also affect coordination of Ca2+ to  this loop, 
consistent w ith  th e  GCAP1-Y99C m utant affecting Ca2+ bind­
ing in FF3, or it may modify th e  interaction w ith  GCs. Since the 
patien t w ith  the  GCAPl - I I 141 changes had no family history of 
retinal disease and since his retinal disease w as very different 
from tha t found in o th er patien ts w ith  GCAPl m utations, this 
m utant w as not further biochem ically characterized.
C o n c l u s io n s
In summary, GCAP1-1143NT stimulated photoreceptor GC effec­
tively at low  [Ca2+J(ree, to  a degree comparable to wild-type 
GCAPl and the  GCAP1-F155G mutant. However, the ( :;r -sensi­
tivity of the GCAPl mutants was markedly altered, causing per­
sistent stimulation of GC w hen exposed to  high Ca2+ levels such 
as those present in dark-adapted photoreceptors. This activity is 
consistent w ith the dominant phenotype produced by the mutant 
alleles causing cone degeneration. Persistent stimulation of GC by 
the mutant proteins is predicted to  lead to  elevated levels of 
cGMP in the dark-adapted retina, w hich in turn causes a higher
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percentage of cGMP-gated channels in the plasma mem brane to 
be open. It is likely that the actual cGMP level in the dark-adapted 
photoreceptors will be a balance betw een the excessive produc­
tion of cGMP by GC stimulated by the m utant GCAPl and hydro­
lysis of cGMP through the basal activity of PDB. The altered 
physiological cGMP levels may be subtle and thus cause a rela­
tively slow retinal degeneration. The reason for the mostly cone- 
specific degeneration in response to  this physiological defect may 
be because GCAPl may be m ore active in cones than rods, or, 
alternatively, it may reflect o ther differences in cGMP metabolism 
betw een rods and cones.
It rem ains unexplained w hy  som e cones in the peripheral 
re tin a11 can survive for over 70 years, w hile rods and cones in 
the fovea and perifovea degenerate. Since the abnorm ality of 
ph o to recep to r physiology in the affected patien ts w ould  be 
ex p ec ted  to occur mainly in darkness o r dim light (persistent 
GC stim ulation in the dark), it is doubtful that reducing light 
exposure (such as by w earing  sunglasses) w ou ld  slow  their 
rate o f progressive visual loss. W hether reducing exposure to 
darkness (such as by keeping lights on at night w hile sleeping) 
w ou ld  be helpful is uncertain . Animal m odels w ith  hom olo­
gous dom inant GCAPl m utations m ight be helpful to  address 
this uncertainty.
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